C92.52
Acute myelomonocytic leukemia, in relapse
Clinical Classification Guidelines
Medical Intelligence & Overview
Acute myelomonocytic leukemia (AML), classified under ICD-10 code C92.52, is a rapidly progressing blood cancer that affects the myeloid cells in the bone marrow. When this condition reappears after treatment, it is termed as leukemia in relapse. This type of leukemia involves the proliferation of abnormal myelomonocytic cells, which interfere with normal blood cell production and function. Recognizing the signs and understanding the nature of relapse are essential for patients and caregivers to plan appropriate medical responses.
Causes & Symptoms
Clinical Causes: Persistence of minimal residual disease (remaining leukemic cells post-treatment) Genetic mutations acquired during or after initial therapy Ineffectiveness of previous treatment regimens against resistant leukemia cell clones Immunological factors that allow leukemic cells to evade detection Environmental exposures that may promote leukemic cell growth
Key Symptoms: Fatigue and weakness due to anemia Frequent or severe infections resulting from low white blood cell counts Easy bruising or bleeding, such as nosebleeds or bleeding gums Unexplained fever or night sweats Pain or swelling in bones or joints Weight loss and loss of appetite Shortness of breath or dizziness
Diagnostic & Treatment
Diagnosis Path: Complete blood count (CBC) to check for abnormal blood cell levels Bone marrow biopsy to examine marrow for leukemic cells Cytogenetic analysis and molecular testing to identify genetic mutations Flow cytometry to characterize the types of cells present in blood and marrow Imaging tests if there are signs of organ involvement
Treatment Protocols: Chemotherapy regimens, often involving different drugs or doses to combat resistant cells Targeted therapies aimed at specific genetic mutations identified in leukemic cells Stem cell or bone marrow transplantation, especially if prior treatments have failed Supportive care to manage symptoms and prevent complications during treatment Participation in clinical trials exploring new therapies
Clinical Advice & FAQs
Billing Guidance
Is C92.52 a billable ICD-10 code?
Yes, C92.52 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C92.52?
Clinical documentation must specify the nature of Acute myelomonocytic leukemia, in relapse and any associated comorbidities for accurate reporting.
Cite this Clinical Reference